EUVIMEDEUVIMED entdecken
Crossref

Discovery of Potent CDK2 Inhibitors Through Structure‐Based Virtual Screening and MD Simulation Studies

Dharmesh A Patel, Apurva S Prajapati, Siddharth S Patel, Ranjitsinh C Dabhi, Dushyant D Kotadiya, Hitesh D Patel

Biotechnology and Applied Biochemistry · 20.08.2026

DOI: 10.1002/bab.70202 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology and Applied Biochemistry, online erschienen am 20.08.2026. Verfasst von Dharmesh A Patel und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, School of Sciences, Gujarat University, Ahmedabad, Gujarat, India. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cyclin‐dependent kinase 2 (CDK2) is a crucial regulator of the cell cycle and a promising target for cancer treatment. In this study, five known inhibitors were used to create a receptor‐based pharmacophore model that includes an aromatic ring, hydrogen bond donors and acceptors, a negatively charged group, and a hydrophobic region. This model screened the Asinex database and found 1881 hits. Molecular docking narrowed the selection to the 10 best candidates (MD1–MD10), with MD1–MD5 showing strong binding affinities, with docking scores between −11.66 and −10.56 kcal/mol. These five compounds were further tested using ADME/T profiling, DFT calculations, and 100 ns molecular dynamics simulations. Principal component analysis (PCA) and free energy landscape (FEL) evaluations further confirmed stable conformational behavior across the MD simulation trajectories. The HOMO–LUMO gaps suggested stable electronic properties, and the MD simulations confirmed complex stability, with RMSD and RMSF values ranging from 2.0 to 2.8 Å. Overall, MD1–MD5 demonstrated excellent binding, structural stability, and pharmacokinetic properties, making them strong candidates for future CDK2‐targeted anticancer research.

Schlagwörter

Stichwörter der Autor:innen

CDK2 inhibitorsE‐pharmacophore modelingcancerdensity functional theorymolecular dockingmolecular dynamics simulations

Autor:innen und Institutionen

  • Department of Chemistry, School of Sciences, Gujarat University, Ahmedabad, Gujarat, India.
  • School of Forensic Sciences, Dharwad Campus, National Forensic Sciences University, Dharwad, Karnataka, India.

Zitieren

APA

Patel, D. A., Prajapati, A. S., Patel, S. S., Dabhi, R. C., Kotadiya, D. D., & Patel, H. D. (2026). Discovery of Potent CDK2 Inhibitors Through Structure‐Based Virtual Screening and MD Simulation Studies. Biotechnology and Applied Biochemistry. https://doi.org/10.1002/bab.70202

Vancouver

Patel DA, Prajapati AS, Patel SS, Dabhi RC, Kotadiya DD, Patel HD. Discovery of Potent CDK2 Inhibitors Through Structure‐Based Virtual Screening and MD Simulation Studies. Biotechnology and Applied Biochemistry. 2026. doi:10.1002/bab.70202

BibTeX
@article{Patel2026,
  author = {Patel, Dharmesh A and Prajapati, Apurva S and Patel, Siddharth S and Dabhi, Ranjitsinh C and Kotadiya, Dushyant D and Patel, Hitesh D},
  title = {Discovery of Potent CDK2 Inhibitors Through Structure‐Based Virtual Screening and MD Simulation Studies},
  journal = {Biotechnology and Applied Biochemistry},
  year = {2026},
  doi = {10.1002/bab.70202}
}
Kostenlos starten →